GBA1 and Parkinson disease: The screening of a Nigerian cohort for GBA1 variants showed six likely pathogenic variants exclusively in PD patients (p.W184R, p.L383PfsX3, and three p.L444P/L483P), which correspond to 6.5% of this PD cohort [83].